GLP-1 receptor agonists are medications that mimic or enhance GLP-1s activity and are used to treat type 2 diabetes and, more recently, obesity
Left outside
When using GLP-1 medications, you might experience several benefits including a notable reduction in body weight, decreased appetite, improved blood sugar levels, and even some cardiovascular advantages such as a reduced risk of heart attack and stroke in certain individuals
The monitoring priorities it lists are renal function, dehydration risk, and nutritional status
What the Research Says About GLP-1s and HS While clinical research is still in early stages, several studies support what many of us in the HS community have seen anecdotally: A 2024 study of patients with HS found that semaglutide reduced the frequency of flares and systemic inflammationflaring decreased from once every 8.5 weeks to once every 12 weeks
Patients need the appropriate ongoing wraparound support to unlock the health benefits of GLP-1s without the adverse impacts, and healthcare buyers need solutions that help them manage costs while ensuring their members and employees have what they need to get and stay healthy
